SPGI vs CME
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SPGI · S&P Global$467.80 ▼ 0.98%
CME · CME Group$305.89 ▼ 0.44%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SPGI +1.0%
- CME +14.6%
Head to head
| Metric | SPGI | CME |
|---|---|---|
| Price | $467.80 | $305.89 |
| Change today | ▼ 0.98% | ▼ 0.44% |
| Market cap | $135.62B | $109.49B |
| Return, 3 months | +14.1% | +16.6% |
| Return, year to date | -4.7% | +15.8% |
| Return, 1 year | +0.5% | +14.9% |
| P/E (TTM) | 27.8 | 25.1 |
| P/B | 6.9 | 4.1 |
| P/E percentile vs own 5y | 19th | 47th |
| Dividend yield | 0.83% | 3.69% |
| Revenue growth (YoY, latest qtr) | +6.8% | +13.0% |
| Net profit growth (YoY) | +6.6% | +14.2% |
| Gross margin | 71.0% | 86.6% |
| Operating margin | 42.8% | 65.7% |
| Net margin | 30.6% | 63.1% |
| Return on equity | 18.9% | 16.1% |
| Analyst target vs. price | +13.6% | +2.5% |
| Analyst buy share | 100% | 55% |
| RSI (14) | 65 | 64 |
| 30-day volatility | 24.6% | 24.2% |
| Max drawdown, 1 year | -28.5% | -31.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SPGI is the largest of the group by market value.
- CME has returned the most over the past year.
- CME carries the lowest trailing P/E.
- CME pays the highest dividend yield.
- CME is growing revenue fastest.
- CME keeps the most profit per dollar of sales.
- CME has been the calmest stock over the last 30 days.